Skip to content

Medical Device PLI Allocation Hits ₹266.64 Crore for FY 2024‑25, Says JP Nadda

By News Analysis India · · 1 min read

In a Lok Sabha briefing on July 24, Union Minister JP Nadda revealed that the central government will disburse ₹266.64 crore under the Production Linked Incentive (PLI) scheme for medical‑device manufacturers for FY 2024‑25. A further ₹209.80 crore has been earmarked for the Medical Device Park scheme.

Nadda noted that of the park allocation, ₹177.98 crore has already been utilised. Under the Strengthening Medical Devices Industry (SMDI) drive, the Marginal Investment Scheme – R&D (MIS‑RID) has approved projects worth ₹101.50 crore to reduce import dependence, while the Shared Facility for Medical Device Clusters (CFMDC) component cleared projects totalling ₹88.67 crore, with ₹20.62 crore released to date.

The minister stressed that the government has introduced several initiatives to promote the domestic production of high‑end, precision medical equipment, thereby lowering reliance on foreign imports.

The PLI scheme’s total budget is ₹3,420 crore, targeting enhanced sales in four key segments: cancer care and radiotherapy, radiology and imaging, anesthetic devices, and cardio‑respiratory‑renal care equipment including implants.

To date, 27 proposals have received approval, including 14 MSMEs. Approved entities have invested ₹1,153.07 crore, initiating Indian‑made production of MRI and CT scanners, LINACs, mammography units, C‑Arm devices, ultrasound machines, heart valves and vascular stents.

The Medical Device Park scheme, with a ₹300 crore envelope, supports the creation of shared infrastructure such as testing facilities, sterilisation units, warehouses, incubators and prototyping labs. The central government can grant up to ₹100 crore per park. Ongoing park projects are located in Noida (U.P.), Ujjain (M.P.) and Kanchipuram (T.N.).